NeuroSense Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a company developing treatments for severe neurodegenerative...
United Kingdom Neurosense Therapeutics Ltd European Medicines Agency Drug Administration Prnewswire Neurosense Therapeutics Ltd Sense Therapeutics
Source: prnewswire.com